Skip to main content
Year archive

SYNAIRGEN PLC — 2018 filings

All 18 regulatory filings released by SYNAIRGEN PLC (SNG) in 2018, sourced directly from the official regulator.

18 Filings
2018 Period
2018 filings (18)
Filing Released Lang
Holding(s) in Company
Regulatory Filings
2018-10-22 English
Part 2 start of Phase II COPD trial
Regulatory Filings
2018-10-22 English
Holding(s) in Company
Major Shareholding Notification
2018-10-16 English
Holding(s) in Company
Regulatory Filings
2018-10-15 English
Result of General Meeting
AGM Information
2018-10-12 English
Result of Fundraise
Share Issue/Capital Change
2018-09-25 English
Proposed Fundraise to raise c.£2.9 million
Capital/Financing Update
2018-09-25 English
Half-year Report
Earnings Release H1 2018
2018-09-25 English
Positive SNG001 Biomarker Data in COPD Patients
Regulatory Filings
2018-06-28 English
Holding(s) in Company
Regulatory Filings
2018-06-26 English
Result of AGM
AGM Information
2018-06-22 English
Synairgen Safety Data with SNG001 in COPD Patients
Regulatory Filings
2018-06-22 English
Holding(s) in Company
Regulatory Filings
2018-04-16 English
Holding(s) in Company
Regulatory Filings
2018-04-03 English
Issue of Equity
Share Issue/Capital Change
2018-03-15 English
Holding(s) in Company
Major Shareholding Notification
2018-03-15 English
Preliminary results for year ended 31 Dec 2017
Earnings Release FY 2017
2018-03-15 English
Synairgen starts dosing in Phase II COPD study
Regulatory Filings
2018-02-07 English